The short version
10 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Linezolid · LINEZOLID 2 mg/mL · Injection, Solution · Intravenous · Fresenius Kabi USA, LLC
NDC 63323-0713-13 · 10 BAG in 1 CASE / 300 mL in 1 BAG · ANDA · View full market →
10 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.
Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Not scored — fragility is computed for NADAC-priced NDCs.
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Pharmacia & Upjohn Company LLC | LINEZOLID 600 mg/300mL | Jul 15, 2026 | Sep 3, 2026 |
| Caplin Steriles Limited | LINEZOLID 600 mg/300mL | Jul 15, 2026 | Sep 2, 2026 |
| Eugia US LLC | LINEZOLID 600 mg/300mL | Jul 15, 2026 | Sep 2, 2026 |
| Fresenius Kabi USA, LLC | LINEZOLID 2 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Hikma Pharmaceuticals USA Inc. | LINEZOLID 600 mg/300mL | Jul 15, 2026 | Sep 2, 2026 |
| Hospira, Inc. | LINEZOLID 2 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Hp Halden Pharma AS | LINEZOLID 200 mg/100mL | Jul 15, 2026 | Sep 2, 2026 |
| Hp Halden Pharma AS | LINEZOLID 2 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Hp Halden Pharma AS | LINEZOLID 600 mg/300mL | Jul 15, 2026 | Sep 2, 2026 |
| Piramal Critical Care Inc | LINEZOLID 600 mg/300mL | Jul 15, 2026 | Sep 2, 2026 |
| Sandoz Inc | LINEZOLID 600 mg/300mL | Jul 15, 2026 | Sep 2, 2026 |
| Sun Pharmaceutical Industries, Inc. | LINEZOLID 600 mg/300mL | Jul 15, 2026 | Sep 2, 2026 |
| Sun Pharmaceutical Industries, Inc. | LINEZOLID 200 mg/100mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Linezolid — NDC 63323-0713-13," retrieved September 3, 2026, https://drugdashboards.com/drug/63323071313.
Free to cite with attribution — see how the data is put together.